Company / Total Assets
Compass Therapeutics, Inc. Total Assets History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$140.4M
FY2024
5-year range
$51.9M / $199.6M
FY2020-FY2024
Trend
-10.5%
vs FY2023
Sector context
#208 of 216
Health Care
What the data says
Among 216 Health Care companies, Compass Therapeutics, Inc. is in the bottom 4% for total assets. Declined from $200M to $140M over the past 2 years.
Based on SEC 10-K filings.
$140M in FY2024 with a 5-year CAGR of +35.8%.
Declined from $200M to $140M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -3.0%
- 5-Year CAGR
- +35.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 216This company $140.4M Sector average $7.4B
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +35.8%, indicating consistent growth.
- In FY2024, total assets decreased 10.5% year-over-year.
- Ranks #208 out of 216 companies in the Health Care sector.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $140.4M | -10.5% |
| FY2023 | $156.9M | -21.4% |
| FY2022 | $199.6M | +29.8% |
| FY2021 | $153.8M | +196.2% |
| FY2020 | $51.9M | +70.9% |
| FY2019 | $30.4M | +121523900.0% |
| FY2018 | $25 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026